Smoking and acute coronary heart disease: a comparative study

Area of Science:

• Cardiology
• Clinical Medicine
• Public Health

Background:

• Myocardial infarction (MI) is a leading cause of mortality worldwide.
• Smoking is a major risk factor for cardiovascular disease, including MI.
• Understanding differences between smokers and non-smokers post-MI is crucial for targeted treatment.

Purpose of the Study:

• To investigate smoking-related differences in the clinical presentation of first-time myocardial infarction patients.
• To analyze in-hospital outcomes and prognosis in relation to smoking status.
• To explore potential differences in the nature of coronary artery disease between smokers and non-smokers.

Main Methods:

• Retrospective analysis of 978 patients with a first documented myocardial infarction.
• Comparison of clinical profiles, infarct site distribution, and peak cardiac enzyme concentrations between smokers and non-smokers.
• Evaluation of in-hospital outcomes and prognosis based on smoking status.

Main Results:

• Significant differences in infarct site distribution were observed between smokers and non-smokers.
• Smokers exhibited higher peak cardiac enzyme concentrations compared to non-smokers.
• Contrary to expectations, smokers demonstrated a better in-hospital prognosis than non-smokers.

Conclusions:

• Significant disparities exist in the clinical profile and in-hospital outcomes of myocardial infarction patients who smoke versus those who do not.
• Higher cardiac enzyme levels in smokers did not correlate with a worse prognosis, indicating potential differences in disease pathology.
• These findings suggest that the underlying coronary disease may differ in nature between smokers and non-smokers following a first MI.